Company / Working Capital
Structure Therapeutics Inc. Working Capital History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.5B
FY2025
5-year range
$80.1M / $1.5B
FY2022-FY2025
Trend
+76.2%
vs FY2024
Sector context
#28 of 213
Health Care
What the data says
Structure Therapeutics Inc.'s working capital of $1.5B is higher than 87% of companies in the Health Care sector (FY2025). Working Capital has increased for 3 consecutive years, from $80M in FY2022 to $1.5B in FY2025.
Based on SEC 10-K filings.
$1.5B in FY2025 with a 3-year CAGR of +166.0%. Top quartile in the Health Care sector.
Improved from $449M to $1.5B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +166.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+61.2% above sector average
Key checks
Key Insights
- Structure Therapeutics Inc.'s working capital has grown for 3 consecutive years.
- 3-year CAGR of +166.0%, indicating consistent growth.
- In FY2025, working capital increased 76.2% year-over-year.
- Ranks #28 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5B | +76.2% |
| FY2024 | $855.2M | +90.5% |
| FY2023 | $448.9M | +460.5% |
| FY2022 | $80.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026